“Once-Daily Roflumilast Cream 0.05% for the Treatment of Atopic Dermatitis in Patients Aged 2–5 Years With Diverse Skin Types: Subgroup Analysis From the Phase 3 INTEGUMENT-PED Trial”. 2026. SKIN The Journal of Cutaneous Medicine 10 (2): s745. https://doi.org/10.25251/32bs1796.